OpenURL Connection Search

Select item for more details and to access through your institution.

Abnormal bone marrow findings in patients following treatment with chimeric antigen receptor‐T cell therapy.
Published in:
European Journal of Haematology, 2024, v. 112, n. 1, p. 111, doi. 10.1111/ejh.14068
By:
- Yeung, Cecilia C. S.;
- Woolston, David W.;
- Wu, Vicky;
- Voutsinas, Jenna M.;
- Basom, Ryan;
- Davis, Chris;
- Hirayama, Alexandre V.;
- Naresh, Kikkeri N.
Publication type:
Article
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.
Published in:
Cancer Medicine, 2022, v. 11, n. 22, p. 4104, doi. 10.1002/cam4.4722
By:
- Chalker, Cameron;
- Voutsinas, Jenna M.;
- Wu, Qian Vicky;
- Santana‐Davila, Rafael;
- Hwang, Victoria;
- Baik, Christina S.;
- Lee, Sylvia;
- Barber, Brittany;
- Futran, Neal D.;
- Houlton, Jeffrey J.;
- Laramore, George E.;
- Liao, Jay Justin;
- Parvathaneni, Upendra;
- Martins, Renato G.;
- Eaton, Keith D.;
- Rodriguez, Cristina P.
Publication type:
Article
Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell Lymphoma.
Published in:
2021
By:
- Graf, Solomon A.;
- Cassaday, Ryan D.;
- Morris, Karolyn;
- Voutsinas, Jenna M.;
- Wu, Qian Vicky;
- Behnia, Sanaz;
- Lynch, Ryan C.;
- Krakow, Elizabeth;
- Rasmussen, Heather;
- Chauncey, Thomas R.;
- Kanan, Sandra;
- Soma, Lorinda;
- Smith, Stephen D.;
- Gopal, Ajay K.
Publication type:
journal article
Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy.
Published in:
American Journal of Hematology, 2019, v. 94, n. 8, p. E209, doi. 10.1002/ajh.25505
By:
- Chow, Victor A.;
- Gopal, Ajay K.;
- Maloney, David G.;
- Turtle, Cameron J.;
- Smith, Stephen D.;
- Ujjani, Chaitra S.;
- Shadman, Mazyar;
- Cassaday, Ryan D.;
- Till, Brian G.;
- Tseng, Yolanda D.;
- Warren, Edus H.;
- Shustov, Andrei R.;
- Menon, Manoj P.;
- Bhark, Sandra;
- Acharya, Utkarsh H.;
- Mullane, Erin;
- Hannan, Lindsay M.;
- Voutsinas, Jenna M.;
- Gooley, Ted A.;
- Lynch, Ryan C.
Publication type:
Article
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors.
Published in:
Journal of Palliative Medicine, 2022, v. 25, n. 4, p. 614, doi. 10.1089/jpm.2021.0323
By:
- Chalker, Cameron;
- Santana-Davila, Rafael;
- Voutsinas, Jenna M.;
- Wu, Qian;
- Hwang, Victoria;
- Baik, Christina S.;
- Lee, Sylvia;
- Barber, Brittany;
- Futran, Neal D.;
- Houlton, Jeffrey J.;
- Laramore, George E.;
- Liao, Jay Justin;
- Parvathaneni, Upendra;
- Martins, Renato G.;
- Eaton, Keith D.;
- Rodriguez, Cristina P.
Publication type:
Article

Found: 5

Abnormal bone marrow findings in patients following treatment with chimeric antigen receptor‐T cell therapy.

Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.

Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell Lymphoma.

Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy.

High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors.